Brown Advisory Inc. Purchases 94,719 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Brown Advisory Inc. boosted its stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 6.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,628,747 shares of the company's stock after purchasing an additional 94,719 shares during the quarter. Brown Advisory Inc. owned about 6.71% of OrthoPediatrics worth $40,116,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of KIDS. Bank of New York Mellon Corp lifted its stake in OrthoPediatrics by 3.8% in the 4th quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company's stock worth $1,338,000 after purchasing an additional 2,099 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of OrthoPediatrics by 2.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company's stock valued at $3,158,000 after buying an additional 3,800 shares in the last quarter. HighTower Advisors LLC purchased a new stake in shares of OrthoPediatrics during the 4th quarter valued at about $268,000. American Century Companies Inc. raised its position in shares of OrthoPediatrics by 13.2% during the 4th quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock valued at $612,000 after buying an additional 3,072 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of OrthoPediatrics during the 4th quarter valued at about $79,000. Hedge funds and other institutional investors own 69.05% of the company's stock.

OrthoPediatrics Price Performance

NASDAQ KIDS opened at $21.68 on Wednesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 2.99 and a current ratio of 6.19. The firm's 50 day moving average price is $21.49 and its 200-day moving average price is $23.05. OrthoPediatrics Corp. has a 52-week low of $19.52 and a 52-week high of $35.99. The company has a market cap of $526.61 million, a PE ratio of -12.39 and a beta of 1.10.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). OrthoPediatrics had a negative net margin of 19.15% and a negative return on equity of 7.03%. The business had revenue of $52.41 million for the quarter, compared to the consensus estimate of $51.68 million. Sell-side analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Needham & Company LLC restated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. Lake Street Capital began coverage on shares of OrthoPediatrics in a research note on Monday, April 7th. They issued a "buy" rating and a $37.00 target price on the stock. Wall Street Zen upgraded shares of OrthoPediatrics from a "sell" rating to a "hold" rating in a research note on Friday, June 27th. Truist Financial dropped their target price on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Finally, Piper Sandler dropped their target price on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a research note on Thursday, May 8th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $35.83.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.